1. Home
  2. NEPH vs CING Comparison

NEPH vs CING Comparison

Compare NEPH & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • CING
  • Stock Information
  • Founded
  • NEPH 1997
  • CING 2012
  • Country
  • NEPH United States
  • CING United States
  • Employees
  • NEPH N/A
  • CING N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEPH Health Care
  • CING Health Care
  • Exchange
  • NEPH Nasdaq
  • CING Nasdaq
  • Market Cap
  • NEPH 16.8M
  • CING 16.2M
  • IPO Year
  • NEPH 2004
  • CING 2021
  • Fundamental
  • Price
  • NEPH $2.09
  • CING $4.25
  • Analyst Decision
  • NEPH Buy
  • CING Strong Buy
  • Analyst Count
  • NEPH 1
  • CING 4
  • Target Price
  • NEPH $5.00
  • CING $30.67
  • AVG Volume (30 Days)
  • NEPH 7.3K
  • CING 125.0K
  • Earning Date
  • NEPH 05-08-2025
  • CING 05-08-2025
  • Dividend Yield
  • NEPH N/A
  • CING N/A
  • EPS Growth
  • NEPH N/A
  • CING N/A
  • EPS
  • NEPH 0.08
  • CING N/A
  • Revenue
  • NEPH $15,517,000.00
  • CING N/A
  • Revenue This Year
  • NEPH $9.23
  • CING N/A
  • Revenue Next Year
  • NEPH $12.99
  • CING N/A
  • P/E Ratio
  • NEPH $28.58
  • CING N/A
  • Revenue Growth
  • NEPH 10.34
  • CING N/A
  • 52 Week Low
  • NEPH $1.36
  • CING $1.80
  • 52 Week High
  • NEPH $2.55
  • CING $20.83
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 57.94
  • CING 55.08
  • Support Level
  • NEPH $1.88
  • CING $3.83
  • Resistance Level
  • NEPH $2.23
  • CING $4.15
  • Average True Range (ATR)
  • NEPH 0.17
  • CING 0.30
  • MACD
  • NEPH 0.01
  • CING -0.02
  • Stochastic Oscillator
  • NEPH 69.23
  • CING 64.94

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: